Log In
BCIQ
Print this Print this
 

lemuteporfin (DRM05)

  Manage Alerts
Collapse Summary General Information
Company Dermira Inc.
DescriptionTopical formulation of lemuteporfin (photosensitizer)
Molecular Target
Mechanism of ActionPhotodynamic therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAcne
Indication DetailsTreat acne; Treat moderate to severe acne
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/24/2011

Undisclosed

Undisclosed

0

05/31/2010

Undisclosed

0

0

Get a free BioCentury trial today